3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Multiple Myeloma
5
Breast Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
3
Melanoma
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Carcinoma, Non-Small-Cell Lung
3
Myelodysplastic Syndromes
2
Lymphoma, Mantle-Cell
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hematologic Neoplasms
2
Craniopharyngioma
2
COVID-19
2
Burkitt Lymphoma
2
Arthritis, Rheumatoid
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Unresectable Pancreatic Carcinoma
1
Triple Negative Breast Neoplasms
1
Stroke
1
Sarcoma
1
Respiratory Tract Infections
1
Recurrence
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Pleural Effusion, Malignant
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
Infliximab
3
Fecal Microbiota Transplantation
3
vedolizumab
2
Prednisone
2
LDP-02
2
Immunoglobulin G
2
Disulfides
2
CT-P13
2
tocilizumab
1
prednylidene
1
fish oil triglycerides
1
deltacortene
1
Standard of Care
1
Practice Guidelines as Topic
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Loperamide
1
Injections
1
Endoscopy
1
Diagnosis
1
Colonoscopy
1
Cell- and Tissue-Based Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Colitis
×
tocilizumab
×
Clear all
NCT03601611
2020-04-21
COLAR
Herlev Hospital
Phase NA
Completed
20 enrolled